Avapritinib treatment of aggressive systemic mastocytosis with a novel KIT exon 17 mutation
{{output}}
Background: Systemic mastocytosis is a rare hematologic malignancy that leads to the accumulation of neoplastic mast cells in the bone marrow, visceral organs, and skin. Mutations in the receptor tyrosine kinase, KIT are seen in ... ...
